JP2006022045A - METHOD FOR ISOLATING AND PURIFYING OPTICALLY ACTIVE 1-t-BUTOXYCARBONYL-3-AMINOPYRROLIDINE SALT - Google Patents
METHOD FOR ISOLATING AND PURIFYING OPTICALLY ACTIVE 1-t-BUTOXYCARBONYL-3-AMINOPYRROLIDINE SALT Download PDFInfo
- Publication number
- JP2006022045A JP2006022045A JP2004201784A JP2004201784A JP2006022045A JP 2006022045 A JP2006022045 A JP 2006022045A JP 2004201784 A JP2004201784 A JP 2004201784A JP 2004201784 A JP2004201784 A JP 2004201784A JP 2006022045 A JP2006022045 A JP 2006022045A
- Authority
- JP
- Japan
- Prior art keywords
- butoxycarbonyl
- aminopyrrolidine
- optically active
- salt
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- CMIBWIAICVBURI-UHFFFAOYSA-N tert-butyl 3-aminopyrrolidine-1-carboxylate Chemical class CC(C)(C)OC(=O)N1CCC(N)C1 CMIBWIAICVBURI-UHFFFAOYSA-N 0.000 title claims abstract description 68
- 238000000034 method Methods 0.000 title claims abstract description 44
- 239000013078 crystal Substances 0.000 claims abstract description 35
- 239000002253 acid Substances 0.000 claims abstract description 28
- 150000003839 salts Chemical class 0.000 claims abstract description 21
- 239000012535 impurity Substances 0.000 claims abstract description 11
- 239000012452 mother liquor Substances 0.000 claims abstract description 5
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 27
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 19
- 238000000746 purification Methods 0.000 claims description 12
- 238000002425 crystallisation Methods 0.000 claims description 11
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 claims description 10
- 238000002955 isolation Methods 0.000 claims description 9
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 claims description 8
- 230000008025 crystallization Effects 0.000 claims description 7
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 claims description 6
- 229910000041 hydrogen chloride Inorganic materials 0.000 claims description 6
- 229940098779 methanesulfonic acid Drugs 0.000 claims description 5
- 229910052799 carbon Inorganic materials 0.000 claims description 4
- 125000004432 carbon atom Chemical group C* 0.000 claims description 4
- 229910000042 hydrogen bromide Inorganic materials 0.000 claims description 4
- ZUTOCWURUBEKBL-UHFFFAOYSA-N tert-butyl 3-[(2-methylpropan-2-yl)oxycarbonylamino]pyrrolidine-1-carboxylate Chemical compound CC(C)(C)OC(=O)NC1CCN(C(=O)OC(C)(C)C)C1 ZUTOCWURUBEKBL-UHFFFAOYSA-N 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 abstract description 3
- YMKZLQSZKUSQHZ-UHFFFAOYSA-N ditert-butyl 2-aminopyrrolidine-1,3-dicarboxylate Chemical compound CC(C)(C)OC(=O)C1CCN(C(=O)OC(C)(C)C)C1N YMKZLQSZKUSQHZ-UHFFFAOYSA-N 0.000 abstract description 2
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 45
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 27
- 230000003287 optical effect Effects 0.000 description 25
- 239000002904 solvent Substances 0.000 description 21
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 18
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 15
- 239000000126 substance Substances 0.000 description 14
- 239000000243 solution Substances 0.000 description 13
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 12
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 12
- 150000001875 compounds Chemical class 0.000 description 9
- 239000012141 concentrate Substances 0.000 description 9
- 238000003756 stirring Methods 0.000 description 9
- -1 for example Substances 0.000 description 8
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 4
- 150000007513 acids Chemical class 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- NGXSWUFDCSEIOO-UHFFFAOYSA-N pyrrolidin-3-amine Chemical compound NC1CCNC1 NGXSWUFDCSEIOO-UHFFFAOYSA-N 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 125000003277 amino group Chemical group 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 239000012450 pharmaceutical intermediate Substances 0.000 description 3
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 2
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 2
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- 150000001735 carboxylic acids Chemical class 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 238000004821 distillation Methods 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 229930195733 hydrocarbon Natural products 0.000 description 2
- 150000002430 hydrocarbons Chemical class 0.000 description 2
- 239000010410 layer Substances 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000012044 organic layer Substances 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 238000010898 silica gel chromatography Methods 0.000 description 2
- 150000003460 sulfonic acids Chemical class 0.000 description 2
- NBQHLWCRRNDFIY-UHFFFAOYSA-N tert-butyl 3-aminopyrrolidine-1-carboxylate;hydrochloride Chemical compound Cl.CC(C)(C)OC(=O)N1CCC(N)C1 NBQHLWCRRNDFIY-UHFFFAOYSA-N 0.000 description 2
- KWQRKOSMSFLBTJ-UHFFFAOYSA-N tert-butyl 3-methylsulfonyloxypyrrolidine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCC(OS(C)(=O)=O)C1 KWQRKOSMSFLBTJ-UHFFFAOYSA-N 0.000 description 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- QBYIENPQHBMVBV-HFEGYEGKSA-N (2R)-2-hydroxy-2-phenylacetic acid Chemical compound O[C@@H](C(O)=O)c1ccccc1.O[C@@H](C(O)=O)c1ccccc1 QBYIENPQHBMVBV-HFEGYEGKSA-N 0.000 description 1
- MIOPJNTWMNEORI-GMSGAONNSA-N (S)-camphorsulfonic acid Chemical compound C1C[C@@]2(CS(O)(=O)=O)C(=O)C[C@@H]1C2(C)C MIOPJNTWMNEORI-GMSGAONNSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- HBVNLKQGRZPGRP-UHFFFAOYSA-N 1-benzylpyrrolidin-3-amine Chemical compound C1C(N)CCN1CC1=CC=CC=C1 HBVNLKQGRZPGRP-UHFFFAOYSA-N 0.000 description 1
- CMZSIQCZAFAEDH-UHFFFAOYSA-N 2,2,2-trifluoro-n-pyrrolidin-3-ylacetamide;hydrochloride Chemical compound Cl.FC(F)(F)C(=O)NC1CCNC1 CMZSIQCZAFAEDH-UHFFFAOYSA-N 0.000 description 1
- PICQEJDBZKDWOD-UHFFFAOYSA-N 2-(benzenesulfonamido)-3-phenylpropanoic acid Chemical compound C=1C=CC=CC=1S(=O)(=O)NC(C(=O)O)CC1=CC=CC=C1 PICQEJDBZKDWOD-UHFFFAOYSA-N 0.000 description 1
- AJEQHWUOYYXHSU-UHFFFAOYSA-N C(=O)=C1NCCC1N Chemical compound C(=O)=C1NCCC1N AJEQHWUOYYXHSU-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 1
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- IWYDHOAUDWTVEP-UHFFFAOYSA-N R-2-phenyl-2-hydroxyacetic acid Natural products OC(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 238000005576 amination reaction Methods 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- FHRRJZZGSJXPRQ-UHFFFAOYSA-N benzyl phenylmethoxycarbonyl carbonate Chemical compound C=1C=CC=CC=1COC(=O)OC(=O)OCC1=CC=CC=C1 FHRRJZZGSJXPRQ-UHFFFAOYSA-N 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 150000008282 halocarbons Chemical class 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 238000007327 hydrogenolysis reaction Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 229960002510 mandelic acid Drugs 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000011085 pressure filtration Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 150000003235 pyrrolidines Chemical class 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 150000003462 sulfoxides Chemical class 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- DYHSDKLCOJIUFX-UHFFFAOYSA-N tert-butoxycarbonyl anhydride Chemical compound CC(C)(C)OC(=O)OC(=O)OC(C)(C)C DYHSDKLCOJIUFX-UHFFFAOYSA-N 0.000 description 1
- WLSYDQGCKDPQPL-CQSZACIVSA-N tert-butyl (3r)-3-(phenylmethoxycarbonylamino)pyrrolidine-1-carboxylate Chemical compound C1N(C(=O)OC(C)(C)C)CC[C@H]1NC(=O)OCC1=CC=CC=C1 WLSYDQGCKDPQPL-CQSZACIVSA-N 0.000 description 1
- WLSYDQGCKDPQPL-AWEZNQCLSA-N tert-butyl (3s)-3-(phenylmethoxycarbonylamino)pyrrolidine-1-carboxylate Chemical compound C1N(C(=O)OC(C)(C)C)CC[C@@H]1NC(=O)OCC1=CC=CC=C1 WLSYDQGCKDPQPL-AWEZNQCLSA-N 0.000 description 1
- WLSYDQGCKDPQPL-UHFFFAOYSA-N tert-butyl 3-(phenylmethoxycarbonylamino)pyrrolidine-1-carboxylate Chemical compound C1N(C(=O)OC(C)(C)C)CCC1NC(=O)OCC1=CC=CC=C1 WLSYDQGCKDPQPL-UHFFFAOYSA-N 0.000 description 1
- AGQSXQUMNKZASE-UHFFFAOYSA-N tert-butyl 3-[(2,2,2-trifluoroacetyl)amino]pyrrolidine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCC(NC(=O)C(F)(F)F)C1 AGQSXQUMNKZASE-UHFFFAOYSA-N 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 238000005979 thermal decomposition reaction Methods 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- 238000003828 vacuum filtration Methods 0.000 description 1
Landscapes
- Pyrrole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
本発明は、医薬中間体として有用な光学活性1−t−ブトキシカルボニル−3−アミノピロリジン塩の単離精製方法に関する。 The present invention relates to a method for isolating and purifying optically active 1-t-butoxycarbonyl-3-aminopyrrolidine salt useful as a pharmaceutical intermediate.
光学活性な1−t−ブトキシカルボニル−3−アミノピロリジンの製造方法並びに単離精製方法としては、以下の方法が知られている。
(1)光学活性な3−アミノピロリジンの1位のアミノ基を選択的にt−ブトキシカルボニル化することにより、光学活性な1−t−ブトキシカルボニル−3−アミノピロリジンを製造し、反応液の濃縮と析出した無機塩をろ別する操作を繰り返した後、ろ液濃縮物を蒸留することによって単離精製する方法(特許文献1)
(2)光学活性な3−アミノピロリジンの1位のアミノ基を選択的にt−ブトキシカルボニル化することにより、光学活性な1−t−ブトキシカルボニル−3−アミノピロリジンを製造し、反応液から溶媒を留去し、酸性水溶液を添加して有機溶媒で洗浄した後、反応液を塩基性に調整して抽出、更に減圧濃縮する方法(特許文献2)
(3)光学活性な1−t−ブトキシカルボニル−3−(ベンジルオキシカルボニルアミノ)ピロリジンをパラジウム触媒存在下に加水素分解した後、触媒をろ別し、ろ液を濃縮後、シリカゲルカラムクロマトグラフィーにて精製、単離する方法(特許文献3)
(4)光学活性な1−t−ブトキシカルボニル−3−(トリフルオロアセチルアミノ)ピロリジンを水酸化リチウムで加水分解した後に中和し、反応液を濃縮する方法(非特許文献1)
(5)光学活性な1−t−ブトキシカルボニル−3−メタンスルホニルオキシピロリジンをアンモニアと反応させた後に、反応液に塩化メチレンを加えて析出する塩をろ別し、ろ液を濃縮する方法(特許文献4)
しかしながら、従来技術(1)では蒸留する前に煩雑な濃縮とろ過操作を繰り返す必要があり、従来技術(2)、(4)、(5)では抽出やろ過操作により無機塩等を除去するだけで、高い精製効果は期待できない。従来技術(3)では高価で煩雑なシリカゲルカラムクロマトグラフィーにて精製を行っており、商業的規模での実施が困難である。更に、これらの方法に共通することは光学異性体が混入した場合に、全く精製できないことが大きな課題である。
The following methods are known as methods for producing and isolating and purifying optically active 1-t-butoxycarbonyl-3-aminopyrrolidine.
(1) Optically active 1-t-butoxycarbonyl-3-aminopyrrolidine is produced by selectively t-butoxycarbonylating the amino group at position 1 of optically active 3-aminopyrrolidine. A method of isolating and purifying the filtrate concentrate by distillation after repeating the operation of concentration and filtering off the precipitated inorganic salt (Patent Document 1)
(2) Optically active 1-t-butoxycarbonyl-3-aminopyrrolidine is produced by selectively t-butoxycarbonylating the amino group at the 1-position of optically active 3-aminopyrrolidine. A method of distilling off the solvent, adding an acidic aqueous solution and washing with an organic solvent, adjusting the reaction solution to basic, extracting, and further concentrating under reduced pressure (Patent Document 2)
(3) Hydrogenolysis of optically active 1-t-butoxycarbonyl-3- (benzyloxycarbonylamino) pyrrolidine in the presence of a palladium catalyst, the catalyst is filtered off, the filtrate is concentrated, and silica gel column chromatography is performed. (PTL 3)
(4) A method in which optically active 1-t-butoxycarbonyl-3- (trifluoroacetylamino) pyrrolidine is hydrolyzed with lithium hydroxide and then neutralized, and the reaction solution is concentrated (Non-patent Document 1).
(5) A method in which optically active 1-t-butoxycarbonyl-3-methanesulfonyloxypyrrolidine is reacted with ammonia, methylene chloride is added to the reaction solution, the precipitated salt is filtered off, and the filtrate is concentrated ( Patent Document 4)
However, in the conventional technique (1), it is necessary to repeat complicated concentration and filtration operations before distillation, and in the conventional techniques (2), (4), and (5), only inorganic salts and the like are removed by extraction and filtration operations. Therefore, a high purification effect cannot be expected. In the prior art (3), purification is performed by expensive and complicated silica gel column chromatography, which is difficult to implement on a commercial scale. Furthermore, what is common to these methods is that it cannot be purified at all when optical isomers are mixed.
このような状況下において、医薬中間体として有用な前記化合物(1)の商業的規模での生産に適した単離精製方法は格別重要な意義を有しており、化学純度の向上だけでなく、同時に光学純度をも向上させることが可能な単離精製方法の確立が望まれる。
本発明は上記現状に鑑みて、高品質の光学活性な1−t−ブトキシカルボニル−3−アミノピロリジンを高い収量で取得でき、簡便且つ効率的に商業的規模で実施できる単離精製方法を提供することが目的である。 In view of the above situation, the present invention provides an isolation and purification method capable of obtaining high-quality optically active 1-tert-butoxycarbonyl-3-aminopyrrolidine in a high yield and capable of being carried out easily and efficiently on a commercial scale. The purpose is to do.
本発明者らは1−t−ブトキシカルボニル−3−アミノピロリジンと酸から塩を形成させて、晶析することで、混入している不純物を効率的に除去出来ることを見出した。 The inventors of the present invention have found that a contaminated impurity can be efficiently removed by forming a salt from 1-t-butoxycarbonyl-3-aminopyrrolidine and an acid and crystallization.
即ち、本発明は、下記式(1); That is, the present invention provides the following formula (1);
本発明によれば、高品質の光学活性な1−t−ブトキシカルボニル−3−アミノピロリジンを高い収量で取得でき、簡便且つ効率的に商業的規模で1−t−ブトキシカルボニル−3−アミノピロリジンの単離精製を実施することが可能である。 According to the present invention, high-quality optically active 1-t-butoxycarbonyl-3-aminopyrrolidine can be obtained in high yield, and 1-t-butoxycarbonyl-3-aminopyrrolidine can be obtained easily and efficiently on a commercial scale. Can be isolated and purified.
以下に、本発明を詳細に説明する。 The present invention is described in detail below.
本発明で用いる光学活性な1−t−ブトキシカルボニル−3−アミノピロリジンは下記式(1); The optically active 1-t-butoxycarbonyl-3-aminopyrrolidine used in the present invention is represented by the following formula (1);
本発明で用いる光学活性な1−t−ブトキシカルボニル−3−アミノピロリジンは、製造方法により、種々の不純物を含有するが、不純物としては例えば、光学活性な1−t−ブトキシカルボニル−3−アミノピロリジンのエナンチオマーや、下記式(2); The optically active 1-tert-butoxycarbonyl-3-aminopyrrolidine used in the present invention contains various impurities depending on the production method. Examples of the impurities include optically active 1-tert-butoxycarbonyl-3-amino. Pyrrolidine enantiomer, and the following formula (2);
上記WO03/055858や特開2002−275155記載の方法で製造した場合、前記化合物(2)が、不純物として混入することが知られている。また、特開2000−53642に記載の方法では、光学活性な1−t−ブトキシカルボニル−3−(メタンスルホニルオキシ)ピロリジンをアンモニアでアミノ化することにより前記化合物(1)を製造しているが、この方法で得られる前記化合物(1)にはエナンチオマー(鏡像異性体)が一部混入するため、低光学純度のものしか得ることができない。 It is known that the compound (2) is mixed as an impurity when manufactured by the method described in WO03 / 055858 or JP-A-2002-275155. Further, in the method described in JP-A-2000-53642, the compound (1) is produced by amination of optically active 1-t-butoxycarbonyl-3- (methanesulfonyloxy) pyrrolidine with ammonia. Since the compound (1) obtained by this method is partially mixed with enantiomers (enantiomers), only those having low optical purity can be obtained.
一般に、構造の類似した不純物(類縁物質)の除去は難しく、前記不純物群を除去して高品質の目的物を得るためには、優れた単離精製方法を開発する必要があった。本発明者らは鋭意検討の結果、前記化合物(1)と酸から塩を形成させ、晶析することによって混入している不純物、なかでも、前記化合物(1)のエナンチオマーや、前記化合物(2)を母液に残し、該塩を結晶として取得することにより、光学活性な1−t−ブトキシカルボニル−3−アミノピロリジンを塩として単離する方法を開発するに至った。 In general, it is difficult to remove impurities (analogous substances) having a similar structure, and it has been necessary to develop an excellent isolation and purification method in order to obtain the high-quality target product by removing the impurity group. As a result of intensive studies, the inventors of the present invention have formed a salt from the compound (1) and an acid, and crystallized to cause impurities, especially the enantiomer of the compound (1) and the compound (2). ) Was left in the mother liquor and the salt was obtained as crystals, leading to the development of a method for isolating optically active 1-tert-butoxycarbonyl-3-aminopyrrolidine as a salt.
本発明で使用する酸としては、光学活性な酸と非光学活性な酸に分けられ、光学活性な酸としては例えば、カンファースルホン酸等のスルホン酸;リンゴ酸、マンデル酸、酒石酸等のカルボン酸;N−(ベンゼンスルホニル)フェニルアラニン等の窒素上が保護されたアミノ酸が挙げられる。好ましくは安価に入手可能な非光学活性な酸であり、例えば、塩化水素、臭化水素、りん酸、硫酸等の鉱酸;メタンスルホン酸、p−トルエンスルホン酸等のスルホン酸;酢酸、シュウ酸等のカルボン酸等が挙げられる。その中で高収量且つ得られる結晶の吸湿性が低いなどの観点から、塩化水素、臭化水素、メタンスルホン酸、又は酢酸が好ましく、更に結晶のろ過性が良い等の観点から、塩化水素、又は酢酸が特に好ましい。これらの酸は、単独または2種以上を併用して用いることもできる。これら酸としては例えば、取り扱いが容易な塩酸や臭化水素酸のような酸水溶液を使用しても良い。 The acid used in the present invention is classified into an optically active acid and a non-optically active acid. Examples of the optically active acid include sulfonic acids such as camphorsulfonic acid; carboxylic acids such as malic acid, mandelic acid, and tartaric acid. A nitrogen-protected amino acid such as N- (benzenesulfonyl) phenylalanine; Preferably, it is a non-optically active acid which can be obtained at low cost, for example, mineral acids such as hydrogen chloride, hydrogen bromide, phosphoric acid and sulfuric acid; sulfonic acids such as methanesulfonic acid and p-toluenesulfonic acid; Examples thereof include carboxylic acids such as acids. Among them, hydrogen chloride, hydrogen bromide, methanesulfonic acid, or acetic acid is preferable from the viewpoint of high yield and low hygroscopicity of the obtained crystal, and from the viewpoint of good crystal filterability, hydrogen chloride, Or acetic acid is particularly preferred. These acids can be used alone or in combination of two or more. As these acids, for example, acid aqueous solutions such as hydrochloric acid and hydrobromic acid which are easy to handle may be used.
前記酸の使用量は特に限定されないが、前記式(1)で表される光学活性な1−t−ブトキシカルボニル−3−アミノピロリジンと塩を形成させ、結晶として析出させることができる量を使用すれば良く、収率良く、優れた精製効果を得るという観点から、前記式(1)で表される光学活性な1−t−ブトキシカルボニル−3−アミノピロリジンに対して、好ましくは0.1〜3倍モル量、より好ましくは0.5〜1.5倍モル量、更に好ましくは0.8〜1.2倍モル量を用いるとよい。 The amount of the acid used is not particularly limited, but an amount that can form a salt with the optically active 1-tert-butoxycarbonyl-3-aminopyrrolidine represented by the formula (1) and precipitate as crystals is used. From the viewpoint of obtaining an excellent purification effect with a good yield, the optically active 1-tert-butoxycarbonyl-3-aminopyrrolidine represented by the formula (1) is preferably 0.1. -3 times molar amount, more preferably 0.5-1.5 times molar amount, and still more preferably 0.8-1.2 times molar amount.
本発明の単離精製方法は溶媒中で好ましく実施される。本発明で使用することのできる溶媒は有機溶媒であり、例えば、イソプロパノール、エタノール、メタノール等のアルコール類;エチレングリコール、プロピレングリコール等の多価アルコール類;酢酸エチル、酢酸メチル等の脂肪酸エステル類;トルエン、ヘキサン等の炭化水素類;ジエチルエーテル、テトラヒドロフラン、メチルt−ブチルエーテル等のエーテル類;グライム等のポリエーテル類;塩化メチレン等のハロゲン化炭化水素類;ジメチルホルムアミド等のアミド類;ジメチルスルホキシド等のスルホキシド類を挙げることができる。好ましくは、脂肪酸エステル類、炭化水素類、アルコール類であり、更に好ましくは、酢酸エチル、トルエン、ヘキサン、イソプロパノール、エタノールである。これらの溶媒は、単独で用いても2種以上を併用しても良い。また、これら溶媒の種類、使用量、混合比は、取得する塩の溶解度に合わせて適宜選択すれば良い。 The isolation and purification method of the present invention is preferably carried out in a solvent. The solvent that can be used in the present invention is an organic solvent, for example, alcohols such as isopropanol, ethanol, and methanol; polyhydric alcohols such as ethylene glycol and propylene glycol; fatty acid esters such as ethyl acetate and methyl acetate; Hydrocarbons such as toluene and hexane; Ethers such as diethyl ether, tetrahydrofuran and methyl t-butyl ether; Polyethers such as glyme; Halogenated hydrocarbons such as methylene chloride; Amides such as dimethylformamide; Dimethyl sulfoxide and the like The sulfoxides can be mentioned. Preferred are fatty acid esters, hydrocarbons, and alcohols, and more preferred are ethyl acetate, toluene, hexane, isopropanol, and ethanol. These solvents may be used alone or in combination of two or more. Moreover, what is necessary is just to select suitably the kind, usage-amount, and mixing ratio of these solvents according to the solubility of the salt to acquire.
次に、前記式(1)で表される光学活性な1−t−ブトキシカルボニル−3−アミノピロリジンと酸から形成された塩の結晶化方法としては特に限定されないが、例えば以下のような方法が挙げられる。
(a)光学活性な1−t−ブトキシカルボニル−3−アミノピロリジンと酸の水溶液を混合した後、濃縮して水分を留去することにより結晶化させる方法。この場合、水と共沸しうる溶媒(例えば、酢酸エチル、トルエン等)を使用し、共沸効果により水分をより効率的に留去することもできる。
(b)光学活性な1−t−ブトキシカルボニル−3−アミノピロリジンを溶媒中で酸と混合することにより結晶化させる方法。
(c)光学活性な1−t−ブトキシカルボニル−3−アミノピロリジンと酸を溶媒中で混合するか、又は、1−t−ブトキシカルボニル−3−アミノピロリジン塩を溶媒に溶解させた後、冷却して結晶化させる方法。
(d)光学活性な1−t−ブトキシカルボニル−3−アミノピロリジン塩を溶媒に溶解させた後、貧溶媒を添加または貧溶媒に濃縮置換することにより結晶化させる方法。
Next, the method for crystallizing the salt formed from the optically active 1-t-butoxycarbonyl-3-aminopyrrolidine represented by the formula (1) and an acid is not particularly limited. Is mentioned.
(A) A method in which an optically active 1-t-butoxycarbonyl-3-aminopyrrolidine and an aqueous solution of an acid are mixed and then concentrated to distill off water to cause crystallization. In this case, a solvent that can azeotrope with water (for example, ethyl acetate, toluene, etc.) can be used, and water can be more efficiently distilled off due to the azeotropic effect.
(B) A method of crystallizing optically active 1-t-butoxycarbonyl-3-aminopyrrolidine by mixing with an acid in a solvent.
(C) Optically active 1-t-butoxycarbonyl-3-aminopyrrolidine and an acid are mixed in a solvent, or 1-t-butoxycarbonyl-3-aminopyrrolidine salt is dissolved in a solvent and then cooled. And crystallizing.
(D) A method in which an optically active 1-t-butoxycarbonyl-3-aminopyrrolidine salt is dissolved in a solvent, and then crystallized by adding a poor solvent or concentrating to the poor solvent.
前記の結晶化方法は、酸の種類と溶媒の組み合わせにより、適切に選択すれば良い。例えば、塩化水素、又は臭化水素はその水溶液である塩酸、又は臭化水素酸で取り扱う方が容易であるため、(a)の方法が適しており、また、メタンスルホン酸、酢酸等の通常非含水物として使用し易い酸を用いる場合は、(b)の方法を選択するのが好ましい。更に、(a)又は(b)の方法で得たれた塩の懸濁溶液を、(c)の方法にて再溶解した後、冷却して結晶化させる等、(a)、(b)、(c)、(d)の方法を適宜組み合わせて結晶化させることもできる。 The crystallization method may be appropriately selected depending on the combination of the acid type and the solvent. For example, since hydrogen chloride or hydrogen bromide is easier to handle with hydrochloric acid or hydrobromic acid which is an aqueous solution thereof, the method (a) is suitable, and methanesulfonic acid, acetic acid and the like are usually used. In the case of using an acid that is easy to use as a non-hydrous material, it is preferable to select the method (b). Furthermore, the salt suspension obtained by the method (a) or (b) is re-dissolved by the method (c) and then cooled and crystallized, etc. (a), (b), Crystallization can also be performed by appropriately combining the methods (c) and (d).
前記結晶化方法で用いる溶媒としては、前述の溶媒と同じものが挙げられ、(d)の方法で用いる貧溶媒としては、例えば、トルエン、ヘキサン等が挙げられる。 Examples of the solvent used in the crystallization method include the same solvents as those described above, and examples of the poor solvent used in the method (d) include toluene and hexane.
前記(c)、(d)の方法における光学活性な1−t−ブトキシカルボニル−3−アミノピロリジン塩としては例えば、前記(a)、(b)の方法により一旦取得した光学活性な1−t−ブトキシカルボニル−3−アミノピロリジンと酸から形成された塩を使用してもよいし、光学活性な1−t−ブトキシカルボニル−3−アミノピロリジンを製造する際に酸を共存させることにより生成される、光学活性な1−t−ブトキシカルボニル−3−アミノピロリジン塩を使用してもよい。 Examples of the optically active 1-t-butoxycarbonyl-3-aminopyrrolidine salt in the methods (c) and (d) include the optically active 1-t once obtained by the methods (a) and (b). -Butoxycarbonyl-3-aminopyrrolidine and a salt formed from an acid may be used, and it is produced by coexisting an acid in producing optically active 1-tert-butoxycarbonyl-3-aminopyrrolidine. Alternatively, an optically active 1-t-butoxycarbonyl-3-aminopyrrolidine salt may be used.
また、光学活性な1−t−ブトキシカルボニル−3−アミノピロリジン塩を溶媒に溶解させる際に、例えば加熱等を行うこともできる。その場合の加熱温度は特に限定されないが、使用する溶媒種又は混合溶媒種に光学活性な1−t−ブトキシカルボニル−3−アミノピロリジン塩が溶解する温度以上で適切に設定すればよい。また、結晶化の際には種晶を加えてもよい。 In addition, when the optically active 1-t-butoxycarbonyl-3-aminopyrrolidine salt is dissolved in a solvent, for example, heating or the like can be performed. The heating temperature in that case is not particularly limited, but may be appropriately set at a temperature equal to or higher than the temperature at which the optically active 1-tert-butoxycarbonyl-3-aminopyrrolidine salt is dissolved in the solvent species or mixed solvent species to be used. In addition, seed crystals may be added during crystallization.
前記(a)〜(d)の結晶化方法における実施温度は、特に限定されないが、塩の種類と使用する溶媒の種類により適宜選択すればよく、好ましくは使用する溶媒種又は混合溶媒種に光学活性な1−t−ブトキシカルボニル−3−アミノピロリジン塩が溶解する温度未満で、目標とする析出量と結晶の品質に応じて設定すればよい。 The implementation temperature in the crystallization methods (a) to (d) is not particularly limited, but may be appropriately selected depending on the type of salt and the type of solvent used. What is necessary is just to set according to the target precipitation amount and the quality of a crystal | crystallization below the temperature which active 1-t-butoxycarbonyl-3-aminopyrrolidine salt melt | dissolves.
前記(a)〜(d)の結晶化方法により、析出した光学活性な1−t−ブトキシカルボニル−3−アミノピロリジン塩の結晶は、減圧ろ過、加圧ろ過又は遠心分離等の方法により分離、取得することができる。また、取得結晶中に母液が残存して結晶の純度が低下する場合は、必要に応じ、更に溶媒で洗浄することにより品質を高めることもできる。
結晶の乾燥方法としては、熱分解や溶融を避けて約60℃以下で、減圧乾燥(真空乾燥)するのが望ましい。
The crystals of the optically active 1-t-butoxycarbonyl-3-aminopyrrolidine salt precipitated by the crystallization methods (a) to (d) are separated by a method such as vacuum filtration, pressure filtration, or centrifugation, Can be acquired. Further, when the mother liquor remains in the acquired crystal and the purity of the crystal is lowered, the quality can be improved by further washing with a solvent, if necessary.
As a method for drying the crystals, it is desirable to dry under reduced pressure (vacuum drying) at about 60 ° C. or less while avoiding thermal decomposition and melting.
前記方法によって取得した光学活性な1−t−ブトキシカルボニル−3−アミノピロリジン塩は、化学純度と共に、光学純度も向上しており、そのまま医薬中間体の原料として用いることもできるが、更に水酸化アルカリ金属等の塩基で処理することにより、前記式(1)で表される光学活性な1−t−ブトキシカルボニル−3−アミノピロリジンを遊離させ、抽出、濃縮等の操作を行うことにより、化学純度及び光学純度の向上した前記化合物(1)を取得することもできる。 The optically active 1-tert-butoxycarbonyl-3-aminopyrrolidine salt obtained by the above method has improved chemical purity as well as optical purity, and can be used as a raw material for a pharmaceutical intermediate as it is. By treating with a base such as an alkali metal, the optically active 1-tert-butoxycarbonyl-3-aminopyrrolidine represented by the above formula (1) is liberated, and operations such as extraction, concentration, etc. are carried out. The compound (1) having improved purity and optical purity can also be obtained.
以下に、実施例を挙げて本発明を更に詳しく説明するが、本発明はこれら実施例のみに限定されるものではない。 Hereinafter, the present invention will be described in more detail with reference to examples, but the present invention is not limited to these examples.
尚、以下の実施例における光学純度は、下記方法により決定した。1−t−ブトキシカルボニル−3−アミノピロリジンの塩約10mgとイソプロパノール2ml、トリエチルアミン100mgを混合した後に、二炭酸ジベンジル15mgを加えて約30秒間攪拌、これにヘキサン20mlを加えて試料溶液とした。5μLをHPLCに注入してその面積比から光学純度を算出した。分析カラムにはCHIRALPACK OD−H(ダイセル)4.6mmΦ×250mmを用いた。移動相にはヘキサン/イソプロパノール(95/5(容積比))を用い、流速は1.0mL/分で、カラム温度30℃、検出はUV254nmで行った。(S)−1−t−ブトキシカルボニル−3−ベンジルオキシカルボニルアミノピロリジンの保持時間は16.0分、(R)−1−t−ブトキシカルボニル−3−ベンジルオキシカルボニルアミノピロリジンの保持時間は12.8分であった。 The optical purity in the following examples was determined by the following method. After mixing about 10 mg of 1-t-butoxycarbonyl-3-aminopyrrolidine salt with 2 ml of isopropanol and 100 mg of triethylamine, 15 mg of dibenzyl dicarbonate was added and stirred for about 30 seconds, and 20 ml of hexane was added thereto to prepare a sample solution. 5 μL was injected into the HPLC, and the optical purity was calculated from the area ratio. CHIRALPACK OD-H (Daicel) 4.6 mmΦ × 250 mm was used for the analytical column. Hexane / isopropanol (95/5 (volume ratio)) was used as the mobile phase, the flow rate was 1.0 mL / min, the column temperature was 30 ° C., and the detection was performed at UV254 nm. The retention time of (S) -1-t-butoxycarbonyl-3-benzyloxycarbonylaminopyrrolidine is 16.0 minutes, and the retention time of (R) -1-t-butoxycarbonyl-3-benzyloxycarbonylaminopyrrolidine is 12. 8 minutes.
(参考例1)
東京化成工業(株)より販売されている3−トリフルオロアセチルアミノピロリジン塩酸塩20.8g、N,N−ジイソプロピルエチルアミン18.2ml、塩化メチレン250mlを混合した後に、二炭酸ジ−t−ブチル20.8gの塩化メチレン(25ml)溶液をゆっくりと添加した。室温で2時間攪拌した後に、飽和炭酸ナトリウム水溶液300ml、塩化メチレン500mlを加え、抽出した。水層を塩化メチレン500mlで抽出し、有機層を混合して、減圧下にて溶媒を留去した。残渣を減圧蒸留することにより、1−t−ブトキシカルボニル−3−アミノピロリジン12.2g得た。このものは化学純度98.2重量%、光学純度89.5%ee.(S体過剰)であった。
(Reference Example 1)
After mixing 20.8 g of 3-trifluoroacetylaminopyrrolidine hydrochloride sold by Tokyo Chemical Industry Co., Ltd., 18.2 ml of N, N-diisopropylethylamine and 250 ml of methylene chloride, di-t-butyl dicarbonate 20 .8 g of methylene chloride (25 ml) solution was added slowly. After stirring at room temperature for 2 hours, 300 ml of saturated aqueous sodium carbonate solution and 500 ml of methylene chloride were added for extraction. The aqueous layer was extracted with 500 ml of methylene chloride, the organic layers were mixed, and the solvent was distilled off under reduced pressure. The residue was distilled under reduced pressure to obtain 12.2 g of 1-t-butoxycarbonyl-3-aminopyrrolidine. This had a chemical purity of 98.2% by weight and an optical purity of 89.5% ee. (S body excess).
(実施例1)
化学純度98.2重量%、光学純度89.5%ee(S体過剰)の1−t−ブトキシカルボニル−3−アミノピロリジン0.50gを酢酸エチル5mLに溶解させた。ここに、濃塩酸0.28g(1−t−ブトキシカルボニル−3−アミノピロリジンに対して1.0モル当量)を加えた。この溶液を減圧濃縮し、濃縮物に酢酸エチル15mLを加えて再度濃縮した。得られた濃縮物に酢酸エチル5mLを加えると結晶が析出し、室温で1時間攪拌後、結晶を減圧ろ別し、真空乾燥することにより、1−t−ブトキシカルボニル−3−アミノピロリジンの塩酸塩を0.43g得た。光学純度は98.3%eeまで向上していた。
Example 1
0.50 g of 1-t-butoxycarbonyl-3-aminopyrrolidine having a chemical purity of 98.2% by weight and an optical purity of 89.5% ee (S-form excess) was dissolved in 5 mL of ethyl acetate. To this, 0.28 g of concentrated hydrochloric acid (1.0 molar equivalent relative to 1-t-butoxycarbonyl-3-aminopyrrolidine) was added. The solution was concentrated under reduced pressure, 15 mL of ethyl acetate was added to the concentrate, and the mixture was concentrated again. When 5 mL of ethyl acetate is added to the resulting concentrate, crystals are precipitated. After stirring at room temperature for 1 hour, the crystals are filtered under reduced pressure and dried under vacuum to give hydrochloric acid of 1-tert-butoxycarbonyl-3-aminopyrrolidine. 0.43 g of salt was obtained. The optical purity was improved to 98.3% ee.
(実施例2)
化学純度98.2重量%、光学純度89.5%ee(S体過剰)の1−t−ブトキシカルボニル−3−アミノピロリジン0.50gを酢酸エチル5mLに溶解させた。ここに、酢酸0.16g(1−t−ブトキシカルボニル−3−アミノピロリジンに対して1.0モル当量)を加えた。この溶液を減圧濃縮し、濃縮物にヘキサン20mLを加えると結晶が析出した。室温で1時間攪拌後、結晶を減圧ろ別し、真空乾燥することにより、1−t−ブトキシカルボニル−3−アミノピロリジンの酢酸塩を0.57g得た。光学純度は93.0%eeまで向上していた。
(Example 2)
0.50 g of 1-t-butoxycarbonyl-3-aminopyrrolidine having a chemical purity of 98.2% by weight and an optical purity of 89.5% ee (S-form excess) was dissolved in 5 mL of ethyl acetate. To this, 0.16 g of acetic acid (1.0 molar equivalent relative to 1-t-butoxycarbonyl-3-aminopyrrolidine) was added. This solution was concentrated under reduced pressure, and 20 mL of hexane was added to the concentrate to precipitate crystals. After stirring at room temperature for 1 hour, the crystals were filtered off under reduced pressure and vacuum-dried to obtain 0.57 g of 1-t-butoxycarbonyl-3-aminopyrrolidine acetate. The optical purity was improved to 93.0% ee.
(実施例3)
化学純度98.2重量%、光学純度89.5%ee(S体過剰)の1−t−ブトキシカルボニル−3−アミノピロリジン0.50gをエタノール5mLに溶解させた。これにメタンスルホン酸0.26g(1−t−ブトキシカルボニル−3−アミノピロリジンに対して1.0モル当量)を添加した。この溶液を減圧濃縮し、濃縮物に酢酸エチル10mLを加えると結晶が析出した。室温で1時間攪拌後、結晶を減圧ろ別し、真空乾燥することにより、1−t−ブトキシカルボニル−3−アミノピロリジンのメタンスルホン酸塩を0.66g得た。光学純度は91.1%eeまで向上していた。
Example 3
0.50 g of 1-t-butoxycarbonyl-3-aminopyrrolidine having a chemical purity of 98.2% by weight and an optical purity of 89.5% ee (S-form excess) was dissolved in 5 mL of ethanol. To this was added 0.26 g of methanesulfonic acid (1.0 molar equivalent based on 1-t-butoxycarbonyl-3-aminopyrrolidine). The solution was concentrated under reduced pressure, and 10 mL of ethyl acetate was added to the concentrate to precipitate crystals. After stirring at room temperature for 1 hour, the crystals were filtered off under reduced pressure and vacuum dried to obtain 0.66 g of 1-t-butoxycarbonyl-3-aminopyrrolidine methanesulfonate. The optical purity was improved to 91.1% ee.
(実施例4)
化学純度98.2重量%、光学純度89.5%ee(S体過剰)の1−t−ブトキシカルボニル−3−アミノピロリジン0.50gをエタノール5mLに溶解させた。これに塩酸0.28g(1−t−ブトキシカルボニル−3−アミノピロリジンに対して1.0モル当量)を添加した。この溶液を減圧濃縮し、濃縮物にエタノール15mLを加えて再度濃縮し、得られた濃縮物に酢酸エチル10mLを加えると結晶が析出した。室温で1時間攪拌後、結晶を減圧ろ別、真空乾燥することにより、1−t−ブトキシカルボニル−3−アミノピロリジンの塩酸塩を0.42g得た。光学純度は96.9%eeまで向上していた。
Example 4
0.50 g of 1-t-butoxycarbonyl-3-aminopyrrolidine having a chemical purity of 98.2% by weight and an optical purity of 89.5% ee (S-form excess) was dissolved in 5 mL of ethanol. To this was added 0.28 g of hydrochloric acid (1.0 molar equivalent with respect to 1-t-butoxycarbonyl-3-aminopyrrolidine). This solution was concentrated under reduced pressure, 15 mL of ethanol was added to the concentrate, and the mixture was concentrated again. When 10 mL of ethyl acetate was added to the resulting concentrate, crystals were precipitated. After stirring at room temperature for 1 hour, the crystals were filtered off under reduced pressure and vacuum dried to obtain 0.42 g of 1-t-butoxycarbonyl-3-aminopyrrolidine hydrochloride. The optical purity was improved to 96.9% ee.
(実施例5)
化学純度98.2重量%、光学純度89.5%ee(S体過剰)の1−t−ブトキシカルボニル−3−アミノピロリジン0.50gを酢酸エチル5mLに溶解させた。これに酢酸0.14g(1−t−ブトキシカルボニル−3−アミノピロリジンに対して0.9モル当量)を添加した。この溶液にヘキサン25mLを加えると結晶が析出し、室温で1時間攪拌後、結晶を減圧ろ別し、真空乾燥することにより、1−t−ブトキシカルボニル−3−アミノピロリジンの酢酸塩を0.55g得た。光学純度は94.6%eeまで向上していた。
(Example 5)
0.50 g of 1-t-butoxycarbonyl-3-aminopyrrolidine having a chemical purity of 98.2% by weight and an optical purity of 89.5% ee (S-form excess) was dissolved in 5 mL of ethyl acetate. To this was added 0.14 g of acetic acid (0.9 molar equivalents relative to 1-t-butoxycarbonyl-3-aminopyrrolidine). When 25 mL of hexane is added to this solution, crystals are precipitated. After stirring at room temperature for 1 hour, the crystals are filtered off under reduced pressure and dried under vacuum to give 1-tert-butoxycarbonyl-3-aminopyrrolidine acetate as a salt. 55 g was obtained. The optical purity was improved to 94.6% ee.
(実施例6)
化学純度98.2重量%、光学純度89.5%ee(S体過剰)の1−t−ブトキシカルボニル−3−アミノピロリジン0.50gを酢酸エチル10mLに溶解させた。これに酢酸0.14g(1−t−ブトキシカルボニル−3−アミノピロリジンに対して0.9モル当量)を添加した。この溶液にヘキサン15mLを加えると結晶が析出した。これを50℃に加温して結晶を溶解させた後に、5℃まで徐々に冷却することにより、結晶が析出した。1時間攪拌後、結晶を減圧ろ別し、真空乾燥することにより、1−t−ブトキシカルボニル−3−アミノピロリジンの酢酸塩を0.57g得た。光学純度は91.6%eeまで向上していた。
(Example 6)
0.50 g of 1-t-butoxycarbonyl-3-aminopyrrolidine having a chemical purity of 98.2% by weight and an optical purity of 89.5% ee (S-form excess) was dissolved in 10 mL of ethyl acetate. To this was added 0.14 g of acetic acid (0.9 molar equivalents relative to 1-t-butoxycarbonyl-3-aminopyrrolidine). When 15 mL of hexane was added to this solution, crystals were precipitated. This was heated to 50 ° C. to dissolve the crystals, and then gradually cooled to 5 ° C. to precipitate crystals. After stirring for 1 hour, the crystals were filtered off under reduced pressure and dried under vacuum to obtain 0.57 g of 1-t-butoxycarbonyl-3-aminopyrrolidine acetate. The optical purity was improved to 91.6% ee.
(実施例7)
化学純度81.8重量%(1−t−ブトキシカルボニル−3−t−ブトキシカルボニルアミノピロリジンを16.8重量%含有)、光学純度89.5%ee(S体過剰)の1−t−ブトキシカルボニル−3−アミノピロリジン0.60gを酢酸エチル5mLに溶解させた。これに酢酸0.14g(1−t−ブトキシカルボニル−3−アミノピロリジンに対して0.9モル当量)を添加した。この溶液にヘキサン15mLを加えると結晶が析出した。室温で1時間攪拌後、結晶を減圧ろ別した。得られた結晶に、酢酸エチル10mL、水2mL、30%水酸化ナトリウム水溶液0.53gを加え、水層を除去した。有機層を減圧濃縮することにより、1−t−ブトキシカルボニル−3−アミノピロリジンを0.35g取得した。化学純度は98.6重量%、1−t−ブトキシカルボニル−3−t−ブトキシカルボニル−アミノピロリジンは完全に除去されており、光学純度は96.9%eeまで向上していた。
(Example 7)
1-t-butoxy having a chemical purity of 81.8% by weight (containing 16.8% by weight of 1-t-butoxycarbonyl-3-t-butoxycarbonylaminopyrrolidine) and optical purity of 89.5% ee (S-form excess) 0.60 g of carbonyl-3-aminopyrrolidine was dissolved in 5 mL of ethyl acetate. To this was added 0.14 g of acetic acid (0.9 molar equivalents relative to 1-t-butoxycarbonyl-3-aminopyrrolidine). When 15 mL of hexane was added to this solution, crystals were precipitated. After stirring at room temperature for 1 hour, the crystals were filtered off under reduced pressure. To the obtained crystals, 10 mL of ethyl acetate, 2 mL of water, and 0.53 g of 30% aqueous sodium hydroxide solution were added, and the aqueous layer was removed. The organic layer was concentrated under reduced pressure to obtain 0.35 g of 1-t-butoxycarbonyl-3-aminopyrrolidine. The chemical purity was 98.6% by weight, 1-t-butoxycarbonyl-3-t-butoxycarbonyl-aminopyrrolidine was completely removed, and the optical purity was improved to 96.9% ee.
(実施例8)
化学純度80.2重量%、光学純度96.6%eeの1−t−ブトキシカルボニル−3−アミノピロリジン0.46gをイソプロパノール4mLに溶解させ、濃塩酸0.21g(1−t−ブトキシカルボニル−3−アミノピロリジンに対して1.0モル当量)を添加し、減圧濃縮した。濃縮物に酢酸エチル8mLを添加すると結晶が析出し、25℃で10分攪拌した後に、結晶を減圧ろ別し、真空乾燥することにより、1−t−ブトキシカルボニル−3−アミノピロリジンの塩酸塩を0.41g得た。光学純度は99.0%eeまで向上していた。この結晶0.35gをイソプロパノール2mLに溶解させた後に減圧濃縮し、濃縮物に酢酸エチル8mLを添加すると結晶が析出し、25℃で10分攪拌した後に、結晶を減圧ろ別し、酢酸エチル2mLにて湿結晶を洗浄した。これを真空乾燥することにより、1−t−ブトキシカルボニル−3−アミノピロリジンの塩酸塩を0.34g得た。光学純度は99.7%eeまで向上していた。
(Example 8)
0.46 g of 1-t-butoxycarbonyl-3-aminopyrrolidine having a chemical purity of 80.2 wt% and an optical purity of 96.6% ee was dissolved in 4 mL of isopropanol, and 0.21 g of concentrated hydrochloric acid (1-t-butoxycarbonyl- 1.0 molar equivalents relative to 3-aminopyrrolidine) was added and concentrated under reduced pressure. When 8 mL of ethyl acetate was added to the concentrate, crystals precipitated. After stirring at 25 ° C. for 10 minutes, the crystals were filtered under reduced pressure and dried under vacuum to give hydrochloride of 1-t-butoxycarbonyl-3-aminopyrrolidine. 0.41 g was obtained. The optical purity was improved to 99.0% ee. 0.35 g of this crystal was dissolved in 2 mL of isopropanol and concentrated under reduced pressure. When 8 mL of ethyl acetate was added to the concentrate, the crystal was precipitated, and stirred at 25 ° C. for 10 minutes. The wet crystals were washed with This was vacuum-dried to obtain 0.34 g of 1-t-butoxycarbonyl-3-aminopyrrolidine hydrochloride. The optical purity was improved to 99.7% ee.
Claims (5)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2004201784A JP2006022045A (en) | 2004-07-08 | 2004-07-08 | METHOD FOR ISOLATING AND PURIFYING OPTICALLY ACTIVE 1-t-BUTOXYCARBONYL-3-AMINOPYRROLIDINE SALT |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2004201784A JP2006022045A (en) | 2004-07-08 | 2004-07-08 | METHOD FOR ISOLATING AND PURIFYING OPTICALLY ACTIVE 1-t-BUTOXYCARBONYL-3-AMINOPYRROLIDINE SALT |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JP2006022045A true JP2006022045A (en) | 2006-01-26 |
Family
ID=35795583
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004201784A Pending JP2006022045A (en) | 2004-07-08 | 2004-07-08 | METHOD FOR ISOLATING AND PURIFYING OPTICALLY ACTIVE 1-t-BUTOXYCARBONYL-3-AMINOPYRROLIDINE SALT |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2006022045A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007297306A (en) * | 2006-04-28 | 2007-11-15 | Kaneka Corp | Method for producing optically active 3-(1-pyrrolidinyl)pyrrolidine |
| JP2012110373A (en) * | 2010-11-19 | 2012-06-14 | Canon Inc | Image processing apparatus and image processing method |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2000514801A (en) * | 1996-07-08 | 2000-11-07 | ローヌ―プーラン ローラー ファーマシューティカルズ インコーポレイテッド | Compounds with anti-hypertensive, cardioprotective, anti-ischemic and anti-lipolytic properties |
| WO2001030745A1 (en) * | 1999-10-25 | 2001-05-03 | Fujisawa Pharmaceutical Co., Ltd. | Anthranilic acid derivatives as inhibitors of the cgmp-phosphodiesterase |
| JP2002275155A (en) * | 2001-01-11 | 2002-09-25 | Sankyo Co Ltd | Method for producing cyclic amine derivative |
| WO2003055858A1 (en) * | 2001-12-27 | 2003-07-10 | Toray Fine Chemicals Co., Ltd. | Process for producing 1-alkoxycarbonyl nitrogenous saturated heterocyclic derivative |
| WO2004013097A1 (en) * | 2002-08-01 | 2004-02-12 | Basilea Pharmaceutica Ag | Process for the preparation of amino-pyrrolidine derivatives |
-
2004
- 2004-07-08 JP JP2004201784A patent/JP2006022045A/en active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2000514801A (en) * | 1996-07-08 | 2000-11-07 | ローヌ―プーラン ローラー ファーマシューティカルズ インコーポレイテッド | Compounds with anti-hypertensive, cardioprotective, anti-ischemic and anti-lipolytic properties |
| WO2001030745A1 (en) * | 1999-10-25 | 2001-05-03 | Fujisawa Pharmaceutical Co., Ltd. | Anthranilic acid derivatives as inhibitors of the cgmp-phosphodiesterase |
| JP2002275155A (en) * | 2001-01-11 | 2002-09-25 | Sankyo Co Ltd | Method for producing cyclic amine derivative |
| WO2003055858A1 (en) * | 2001-12-27 | 2003-07-10 | Toray Fine Chemicals Co., Ltd. | Process for producing 1-alkoxycarbonyl nitrogenous saturated heterocyclic derivative |
| WO2004013097A1 (en) * | 2002-08-01 | 2004-02-12 | Basilea Pharmaceutica Ag | Process for the preparation of amino-pyrrolidine derivatives |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007297306A (en) * | 2006-04-28 | 2007-11-15 | Kaneka Corp | Method for producing optically active 3-(1-pyrrolidinyl)pyrrolidine |
| JP2012110373A (en) * | 2010-11-19 | 2012-06-14 | Canon Inc | Image processing apparatus and image processing method |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR102236806B1 (en) | Process for the preparation of enantiomerically enriched 3-aminopiperidine | |
| JP5097770B2 (en) | Method for preparing Dorzolamide | |
| JPWO1999033785A1 (en) | Methods for producing β-halogeno-α-aminocarboxylic acids, phenylcysteine derivatives, and intermediates thereof | |
| JP5641802B2 (en) | Process for producing diastereomeric salt of (S) -4-[(4-chlorophenyl) (2-pyridyl) methoxy] piperidine | |
| JP5164842B2 (en) | Process for producing optically active 3-amino nitrogen-containing compound | |
| US10919855B2 (en) | Process to prepare n-[2-[(1s)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulphonyl) ethyl]-1, 3-dioxo-2,3-dihydro-1h-isoindol-4yl]acetamide | |
| JP6947354B2 (en) | How to make linagliptin | |
| JP2006022045A (en) | METHOD FOR ISOLATING AND PURIFYING OPTICALLY ACTIVE 1-t-BUTOXYCARBONYL-3-AMINOPYRROLIDINE SALT | |
| WO2011010579A1 (en) | Process for production of optically active nipecotamide | |
| JPH11349565A (en) | Method for producing pyridonecarboxylic acid derivative and intermediate thereof | |
| JP2009023978A (en) | Method for producing trans-2-benzyloxycyclohexylamine | |
| EP2735560A1 (en) | Method for producing optically active 2-methylproline derivative | |
| JP5397706B2 (en) | Method for producing high purity 1-benzyl-3-aminopyrrolidine | |
| JP5503930B2 (en) | Method for purifying 3-amino-1-tert-butoxycarbonylpiperidine and citrate salt thereof | |
| JP2007297306A (en) | Method for producing optically active 3-(1-pyrrolidinyl)pyrrolidine | |
| JP3884063B2 (en) | Cefcapene pivoxil methanesulfonate | |
| RU2741389C1 (en) | Method for preparing intermediate compound for synthesis of medicinal agent | |
| JP2008222593A (en) | Method for purifying alkylaminopyridine | |
| JP5438976B2 (en) | Process for producing optically active 2-arylpiperazine derivatives | |
| CN102245579A (en) | The preparation method of (S)-1-phenyl-1,2,3,4-tetrahydroisoquinoline | |
| JP4752285B2 (en) | Efficient optical resolution of trifluorolactic acid | |
| JP2023548356A (en) | Method for purifying noroxymorphone | |
| CN110003113A (en) | Method for producing optically active pentanoate derivant | |
| JP2003342259A (en) | Method for producing optically active cis-piperidine derivative | |
| WO2007035003A1 (en) | Process for producing optically active piperazine compound |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20070521 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20100928 |
|
| A02 | Decision of refusal |
Effective date: 20110208 Free format text: JAPANESE INTERMEDIATE CODE: A02 |
